| Symbol | SRIMF |
|---|---|
| Name | STEMRIM |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | - |
| Address | 567-0085 Japan 3rd Fl, Saito Bio Incubator 7-7-15 Asagi, Saito |
| Telephone | +81 072-648-7152 |
| Fax | — |
| — | |
| Website | https://stemrim.com/ |
| Incorporation | — |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 7/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | NOT AVAILABLE |
| Reporting Status | International Reporting: Tokyo Stock Exchange |
| CIK | — |
| Description | StemRIM, Inc. engages in the research and development of regeneration inducing medicine. It deals with areas of disease and pipelines, autologous cell sampling devices for medical treatment, autologous stem cell collection, stem cell gene therapy and others. Additional info from OTC: |
No news found.